Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$0.39 - $0.94 $19,149 - $46,154
-49,100 Reduced 96.79%
1,626 $1,000
Q1 2023

May 02, 2023

SELL
$0.79 - $1.91 $68,177 - $164,833
-86,300 Reduced 62.98%
50,726 $42,000
Q4 2022

Jan 30, 2023

BUY
$1.41 - $2.5 $370 - $657
263 Added 0.19%
137,026 $214,000
Q3 2022

Nov 08, 2022

BUY
$1.66 - $2.79 $584 - $982
352 Added 0.26%
136,763 $236,000
Q2 2022

Aug 04, 2022

SELL
$1.44 - $3.98 $459 - $1,269
-319 Reduced 0.23%
136,411 $236,000
Q1 2022

May 05, 2022

BUY
$2.97 - $5.2 $389 - $681
131 Added 0.1%
136,730 $491,000
Q4 2021

Feb 02, 2022

SELL
$4.99 - $7.46 $2,155 - $3,222
-432 Reduced 0.32%
136,599 $682,000
Q3 2021

Nov 02, 2021

SELL
$7.16 - $9.69 $297,583 - $402,735
-41,562 Reduced 23.27%
137,031 $981,000
Q2 2021

Aug 02, 2021

BUY
$6.23 - $10.03 $158,821 - $255,694
25,493 Added 16.65%
178,593 $1.66 Million
Q1 2021

May 11, 2021

BUY
$8.81 - $16.96 $98,672 - $189,952
11,200 Added 7.89%
153,100 $1.42 Million
Q3 2020

Nov 05, 2020

BUY
$9.57 - $27.05 $96,657 - $273,205
10,100 Added 7.66%
141,900 $1.65 Million
Q2 2020

Aug 07, 2020

BUY
$7.14 - $31.69 $477,666 - $2.12 Million
66,900 Added 103.08%
131,800 $3.55 Million
Q4 2018

Feb 08, 2019

SELL
$3.89 - $6.11 $73,521 - $115,479
-18,900 Reduced 22.55%
64,900 $260,000
Q3 2018

Nov 07, 2018

SELL
$3.92 - $5.58 $43,120 - $61,380
-11,000 Reduced 11.6%
83,800 $466,000
Q2 2018

Aug 10, 2018

SELL
$3.88 - $5.16 $199,598 - $265,445
-51,443 Reduced 35.18%
94,800 $372,000
Q1 2018

May 10, 2018

BUY
$4.05 - $5.69 $74,115 - $104,127
18,300 Added 14.3%
146,243 $689,000
Q3 2017

Nov 06, 2017

BUY
$5.36 - $6.37 $100,081 - $118,940
18,672 Added 17.09%
127,943 $811,000
Q2 2017

Aug 11, 2017

BUY
N/A
109,271
109,271 $857,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $499M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.